MorphoSys AG revenue breakdown overview

MorphoSys AG revenue for the last year amounted to 263.02 M USD, the most of which — 263.00 M USD — came from its highest performing source at the moment, Innovative Cancer Medicines, the year earlier bringing 297.82 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought MorphoSys AG 233.41 M USD.